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Edited by Veli-Pekka LehtoAbstract The intrinsic pathway of apoptosis was investigated in
cell-free extracts of neurones and astrocytes at various stages of
maturation. Neuronal extracts were activated 65-fold after 3
days, 9-fold after 7 days, and were not activated after 10 days
in culture. In contrast, astrocyte extracts were activated to a
similar extent at all stages, up to 60 days in culture. The co-incu-
bation of neuronal and astrocyte extracts followed by addition of
cytochrome c/2 0-deoxyadenosine 5 0-triphosphate led to a 40-fold
activation, suggesting that the development-associated neuronal
shift does not involve the appearance of a dominant inhibitor,
but rather downregulation of some key component(s) involved
in caspase activation.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Neuronal cell death occurs in many diﬀerent physiological
and pathological states, from development to ischaemia to
neurodegeneration. The biochemical pathways underlying
neuronal cell death in these paradigms are of interest from
the standpoints of pathogenesis and potential therapeutics.
One of these pathways is the intrinsic pathway of apoptosis
which is triggered by several stimuli that target mitochondria
and induce cytochrome c (cyt c) release from the mitochondrial
inter-membrane space to the cytosol thus activating the apop-
totic cascade [1,2].
Over the past 10 years, it has been shown that the expression
of mutant proteins associated with neurodegeneration (e.g.,
mutants of copper/zinc superoxide dismutase that are associ-
ated with familial amyotrophic lateral sclerosis) leads to apop-
tosis in cultured neuronal cells [3–5]. However, in vivo, the cell
loss associated with neurodegenerative diseases is, in at least
some cases, non-apoptotic [6,7]. Among the many possible
explanations for this combination of observations are two
for which there is experimental support: ﬁrst, alternative,
non-apoptotic cell death programs have been shown to existAbbreviations: cyt c, cytochrome c; dATP, 2 0-deoxyadenosine
5 0-triphosphate; DEVD-AMC, Acetyl-Asp-Glu-Val-Asp-7-amino-4-
methylcoumarin; LEHD-AMC, Acetyl-Leu-Glu-His-Asp-7-amino-4-
methylcoumarin
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doi:10.1016/j.febslet.2005.09.087[8,9], and it is possible that some of the neuronal cell death
in neurodegenerative diseases may proceed via these alterna-
tive pathways [10]; second, a developmental shift has been
shown to occur in the apostat, such that the intrinsic pathway
is progressively inactivated in association with downregulation
of the apoptotic protease activation factor-1 (Apaf-1) and cas-
pase-3 [11]. The apostat was ﬁrst described as a hypothetical
entity that refers to the set point of the cell with respect to
apoptosis [12,13] and later was ascribed to mitochondria
[14]. Previous studies showed that an apostat shift could be
reproduced in cultured neurones [11], however, the caspase
activation pattern of a glial population such as astrocytes re-
mains unknown. In this work, we investigated the activation
of the intrinsic pathway of apoptosis using cell-free extracts
from primary cultures of neurones and astrocytes at various
stages of maturation. The ability of astrocytes and neurones
to demonstrate such a shift was compared. Furthermore, when
we found that astrocytes did not display the shift, we used a
combination of astrocyte and neurone extracts to determine
the nature of the shift displayed by neurones. Our results sup-
port the proposal that the development-associated neuronal
apostat shift is not associated with the expression of a domi-
nant inhibitor of apoptosis, but rather is associated with the
downregulation of a crucial component or components re-
quired for apoptosis activation such as Apaf-1 and caspase-3
[11]. In contrast, astrocytes may not undergo the maturation-
associated shift seen in neurones.2. Materials and methods
2.1. Materials
The trinucleotide 2 0-deoxyadenosine 5 0-triphosphate (dATP), phos-
phate-buﬀered saline, pH 7.4 (PBS), HEPES buﬀer (1 M), heat-inacti-
vated fetal bovine serum, and the cell culture reagents MEM media,
neurobasal media, GlutaMAX-I, and B-27 supplement were from
Invitrogen. Cytosine arabinoside (Ara-C), the antibiotic solution pen-
icillin/streptomycin and horse heart cyt c were from Sigma–Aldrich.
The caspase substrates acetyl-Asp-Glu-Val-Asp-7-amino-4-methyl-
coumarin (DEVD-AMC) and acetyl-Leu-Glu-His-Asp-7-amino-4-
methylcoumarin (LEHD-AMC) were obtained from Enzyme Systems
Products. 10 mM stock solutions of the substrates was prepared in di-
methyl sulfoxide (DMSO). All other reagents were purchased from
Sigma–Aldrich unless otherwise stated.
2.2. Primary cultures
Experimental animals used in these studies fulﬁl all the requirements
stated by NIH and IACUC guidelines. Primary cultures of cortical
neurones and astrocytes were prepared as described [15]. Brieﬂy,
primary astrocyte cultures were derived from one day old rat pupsblished by Elsevier B.V. All rights reserved.
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Fig. 1. Time dependence of the cyt c/dATP activation of neuronal and
astrocyte extracts. 30 lg of cell-free extracts of primary cultures of
astrocytes (A) or cortical neurones (B) at diﬀerent stages of maturation
were activated with cyt c/dATP. The reaction was followed ﬂuoro-
metrically after addition of DEVD-AMC substrate. The bars represent
the steady-state rates of substrate hydrolysis. Control and cyt c/dATP
treated samples are indicated with white and black squares, respec-
tively. The details of the experiments are described in Section 2.
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um and 1% penicillin/streptomycin for 7–60 days at 37 C and in 5%
carbon dioxide atmosphere. Primary cortical neurones were estab-
lished from day 17 Sprague–Dawley rat embryos. Dissociated cells
were seeded onto 10-cm poly-D-lysine coated plastic dishes and incu-
bated in neurobasal medium containing 1 mM GlutaMAX-I and B-
27 supplement. The cells were seeded at a density of 3 · 105 cells and
cultured at 37 C in a 5% carbon dioxide atmosphere for 3–10 days.
Glial growth was prevented by adding Ara-C to the culture media to
25 lM.
2.3. Preparation of cell-free extracts
All steps were carried out at 4 C unless otherwise stated. Cell-free
extracts from neuronal and astrocytes were prepared according to a
modiﬁed procedure in which the addition of protease inhibitors was
omitted [15]. Cells were washed twice with PBS solution, scrapped
and centrifuged at 1000 · g for 5 min. The pellet was resuspended in
hypotonic buﬀer at 1:1 ratio (w/v) and kept on ice for 30 min to allow
swelling. The cells in suspension were then disrupted by passage
through a 27-gauge needle (Becton–Dickinson) to shear DNA and cen-
trifuged at 16000 · g for 30 min in a refrigerated Eppendorf 5417R
centrifuge. The pellet was discarded and the supernatant consisting
of a cytosolic extract and light membrane structures (S16) was ali-
quoted and stored at 80 C until used. The hypotonic buﬀer consisted
of 20 mM piperazine-1,4-bis(2-ethane)sulfonic acid (Pipes) buﬀer, pH
7.4, containing 10 mM potassium chloride, 5 mM sodium EGTA,
2 mM magnesium chloride and 1 mM dithiothreitol.
2.4. Kinetics of activation
Caspase activity was measured according to a procedure modiﬁed
from that described [15].
Prior to the kinetic measurements the substrates DEVD-AMC and
LEHD-AMC were dissolved in assay buﬀer consisting of 50 mM 4-
(2-hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES) buﬀer, pH
7.4, containing 1 mM EDTA, 100 mM sodium chloride, 10% sucrose
(w/v), 0.1% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulf-
onate (Chaps) (w/v), and 10 mM dithiothreitol.
30 lg of cell-free extracts of astrocytes or cortical neurones at diﬀer-
ent stages of maturation was activated with 10 lM horse heart cyt c
and 1 mM dATP at 37 C during 60 min. A control experiment was
carried out simultaneously in the absence of cyt c/dATP and gives
the background activity of the sample. The samples were loaded in a
96-well microplate (Costar) and the reaction started by addition of
the substrate (50 lM ﬁnal concentration). The reaction was monitored
continuously for 30 min at 37 C in a thermostated Molecular Devices
SpectraMax Gemini spectroﬂuorimeter, at excitation and emission
wavelengths of 370 and 460 nm, respectively. The steady-state rates
of substrate hydrolysis were obtained from the linear parts of the
curves. Results were expressed in arbitrary units of ﬂuorescence
(AU). The data are reported as means ± S.D. of three independent
experiments.3. Results and discussion
Apoptosis is one of the cell death programs actively involved
during neurodevelopment and neurodegeneration. In order to
understand the possible links between neuronal cell death and
ageing we compared cyt c/dATP induction of the caspase cas-
cade in cell-free extracts of primary cultures of neurones and
astrocytes as a function of time. Cortical neurones were cul-
tured for 3, 7 and 10 days, and astrocytes for 14–60 days. At
deﬁned times, the cells were harvested, cell-free extracts
produced and activated by cyt c/dATP [1,15]. Caspase activity
was monitored using the executioner caspase substrate DEVD-
AMC. Astrocyte extracts were activated by cyt c/dATP to a
similar extent at all stages evaluated (14–60 days) (Fig. 1A).
In contrast, neurone extracts were activated 65-fold after 3-
days, only 9-fold after 7-days in culture, and were not activated
by cyt c/dATP after being in culture for 10 days (Fig. 1B), inagreement with a previous study [11]. Given that neurone
development events that occur in vivo have been shown in a
number of studies to occur at a similar time in primary cell cul-
tures [16], this ﬁnding indicates that the activation of the
intrinsic pathway of apoptosis is age-dependent, and neuronal
cultures can recapitulate this developmental apostat shift.
The diﬀerence between the ﬁndings for neurones and astro-
cytes could be the result of either of two general scenarios.
Neuronal development could be associated with the appear-
ance of a dominant inhibitor of caspase activation (e.g., XIAP
or a functional analogue); alternatively, it is possible that neu-
ronal development is associated with the downregulation of a
critical component or components of the intrinsic apoptotic
pathway. A previous study provided support for the latter pos-
sibility, but did not exclude the coexistence of the former [11].
Therefore, cell-free extracts of 7-day primary cultures of corti-
cal neurones and astrocytes were co-incubated for 1 h at 37 C,
followed by 30 min cyt c/dATP activation. The course of the
reaction was monitored ﬂuorometrically by release of aminom-
ethylcoumarin from the substrates LEHD-AMC and DEVD-
AMC, which were the targets of the initiator caspase 9 and
the executioner caspases-3 and -7, respectively [13]. As assayed
on LEHD-AMC substrate, neuronal and astrocyte extracts
were both activated by cyt c/dATP 8-fold and 13-fold, respec-
tively (Fig. 2A). Co-incubation of neuronal and astrocyte
V. Stoka et al. / FEBS Letters 579 (2005) 6147–6150 6149extracts followed by the addition of cyt c/dATP showed a 23-
fold activation (Fig. 2A) which indicates an additive, rather
than a synergistic eﬀect of neurons and astrocytes. Activation
of executioner caspases was then investigated. When assayed
on DEVD substrate, neuronal and astrocyte extracts were acti-
vated by cyt c/dATP 2-fold and 7-fold, respectively (Fig. 2B).
In contrast to LEHD-AMC, co-incubation of neuronal and
astrocyte extracts followed by addition of cyt c/dATP, gave
a 40-fold activation, thus indicating a synergistic action of neu-
rones and astrocytes and that the eﬀect was further ampliﬁed
by executioner caspases (Fig. 2B).
In order to ensure that the activation measured was due
to caspases, rather than other proteolytic enzymes, the gen-
eral caspase inhibitor Boc-aspartyl(OMe)-ﬂuoromethylketone
(BAF) was added to the samples prior to inducing activa-
tion. The enzymatic activity was abolished, thus conﬁrming
that caspases were indeed responsible for the activation mea-
sured (results not shown).
Increased caspase-3 expression has been reported in some
neurodegenerative diseases such as Alzheimers disease [17],
frontotemporal dementia [18], and HIV-associated dementia
[19], as well as in traumatic brain injury [20]. In Alzheimers
disease, caspase-3 immunoreactivity was seen in neurones,
astrocytes, and blood vessels, and exhibited a high degree of
co-localization with neuroﬁbrillary tangles and senile plaques,0
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Fig. 2. LEHDase and DEVDase activities after cyt c/dATP activation
of neuronal and astrocyte extracts. 30 lg of 7-days cell-free extracts of
neurones and astrocytes was preincubated for 60 min at 37 C followed
by 30 min activation with cyt c/dATP. The reaction was started by
addition of the initiator caspase substrate LEHD-AMC (A) or the
executioner caspase substrate DEVD-AMC (B), and the enzyme
activity monitored ﬂuorometrically over 30 min at 37 C. The bars
represent the steady-state rates of substrate hydrolysis. Control and cyt
c/dATP treated samples are indicated with white and black squares,
respectively. Further details are provided in Section 2.suggesting that activated caspase-3 may be a factor in func-
tional decline, and may play an important role in neuronal cell
death and plaque formation in Alzheimers disease brain [17].
Frontotemporal dementia, a neurodegenerative disease which
aﬀects mainly the frontal and anterior temporal cortex, is asso-
ciated with neuronal loss, gliosis, and microvacuolation of
lamina I–III in these brain regions; activated caspase-3 immu-
noreactivity was detected in both neurones and astrocytes, and
was elevated in frontotemporal dementia cases as compared to
controls [18]. Recent evidence shows cell type-speciﬁc vulnera-
bility to caspases in the central nervous system, thus suggesting
that activation of caspases in human neurones does not lead to
an immediate and rapid process of cell death, but rather may
provoke a protracted form of apoptosis [21]. Caspase-6 doses
less than 0.25 pg/cell induced only 20% cell death within 16
days, but rendered neurones vulnerable to oxidative stress
[21]. Caspase-3 induced neuronal apoptosis in 20% of the cells,
whereas caspases-7 and -8 did not induce apoptosis. In con-
trast, astrocytes underwent apoptosis within 24 h when micro-
injected with caspase-3 but not caspases-6, -7, or -8 [21].
The increase of DEVDase activity found after co-incubation
of neuronal and astrocyte extracts is, at ﬁrst sight, paradoxical
(Fig. 2B). However, the cyt c/dATP activation of neuronal ex-
tracts was time-dependent (Fig. 1B) which can be linked to cas-
pase-3 downregulation [11], whereas the cyt c/dATP activation
of astrocyte extracts remained constant over the broad time
interval examined (14–60 days) (see Fig. 1A). The 40-fold in-
crease in DEVDase activity of the combined extracts demon-
strated a synergistic eﬀect of the entities which ampliﬁed the
caspase cascade (Fig. 2B) but was not seen when monitoring
LEHDase activity (Fig. 2A), where caspase-9 would be the
main enzyme responsible. Moreover, it is very likely that astro-
cyte caspase-3 plays a major role in the observed behaviour
(Fig. 2B) because caspases-6, -7 and/or -8 did not induce apop-
tosis, either in neurones or in astrocytes [21].
Therefore, our ﬁnding of the synergistic activation of the
intrinsic pathway of apoptosis by neurones and astrocytes sug-
gests a new way of looking at caspase activation, in which at
least two compartments may be involved.
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